Free Trial

Teza Capital Management LLC Sells 7,039 Shares of The Clorox Company $CLX

Clorox logo with Consumer Staples background

Key Points

  • Teza Capital Management LLC has reduced its stake in The Clorox Company by 51.2%, now holding 6,702 shares valued at approximately $987,000.
  • Analysts have adjusted their price targets for Clorox, with Wells Fargo lowering it from $138 to $130 and others following suit, reflecting an increasingly cautious outlook on the stock.
  • Clorox has recently increased its quarterly dividend to $1.24 per share, representing a 3.9% dividend yield and showcasing a commitment to shareholder returns.
  • MarketBeat previews the top five stocks to own by October 1st.

Teza Capital Management LLC cut its stake in The Clorox Company (NYSE:CLX - Free Report) by 51.2% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,702 shares of the company's stock after selling 7,039 shares during the period. Teza Capital Management LLC's holdings in Clorox were worth $987,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in CLX. Hsbc Holdings PLC increased its stake in Clorox by 118.8% in the first quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company's stock valued at $159,699,000 after acquiring an additional 589,544 shares during the last quarter. KBC Group NV increased its stake in Clorox by 688.7% in the first quarter. KBC Group NV now owns 587,679 shares of the company's stock valued at $86,535,000 after acquiring an additional 513,171 shares during the last quarter. AQR Capital Management LLC increased its stake in Clorox by 412.1% in the first quarter. AQR Capital Management LLC now owns 598,758 shares of the company's stock valued at $88,167,000 after acquiring an additional 481,846 shares during the last quarter. Man Group plc increased its stake in Clorox by 154.6% in the fourth quarter. Man Group plc now owns 570,503 shares of the company's stock valued at $92,655,000 after acquiring an additional 346,449 shares during the last quarter. Finally, GAMMA Investing LLC increased its stake in Clorox by 11,108.0% in the first quarter. GAMMA Investing LLC now owns 349,130 shares of the company's stock valued at $51,409,000 after acquiring an additional 346,015 shares during the last quarter. Institutional investors own 78.53% of the company's stock.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Jefferies Financial Group reduced their target price on Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a research note on Thursday, June 26th. JPMorgan Chase & Co. raised their price target on Clorox from $133.00 to $135.00 and gave the stock a "neutral" rating in a research report on Monday. UBS Group lowered their price objective on Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a research report on Thursday, July 17th. Wells Fargo & Company cut their target price on shares of Clorox from $138.00 to $130.00 and set an "equal weight" rating on the stock in a report on Friday, September 5th. Finally, Barclays lowered their price target on shares of Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a report on Tuesday, July 15th. One analyst has rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, Clorox presently has an average rating of "Reduce" and an average price target of $142.18.

Get Our Latest Report on CLX

Insider Activity at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the firm's stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer owned 54,221 shares in the company, valued at $6,711,475.38. This trade represents a 21.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.57% of the stock is currently owned by insiders.

Clorox Stock Down 0.1%

Shares of CLX traded down $0.11 on Friday, reaching $124.31. The stock had a trading volume of 525,700 shares, compared to its average volume of 1,662,765. The firm has a market capitalization of $15.20 billion, a price-to-earnings ratio of 19.06, a price-to-earnings-growth ratio of 0.99 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The company has a 50-day simple moving average of $124.30 and a 200-day simple moving average of $132.67. The Clorox Company has a 12-month low of $116.53 and a 12-month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, beating analysts' consensus estimates of $2.24 by $0.63. The company had revenue of $1.99 billion during the quarter, compared to analysts' expectations of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm's revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter last year, the business posted $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Sell-side analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Wednesday, August 13th were paid a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.0%. The ex-dividend date was Wednesday, August 13th. This is a boost from Clorox's previous quarterly dividend of $1.22. Clorox's dividend payout ratio (DPR) is 76.07%.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.